Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Willems, Peter HGM"'
Publikováno v:
Advances in Anatomy Embryology and Cell Biology
Oxidative stress arises from an imbalance between the production of reactive oxygen species (ROS) and their removal by cellular antioxidant systems. Especially under pathological conditions, mitochondria constitute a relevant source of cellular ROS.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______330::726db5c5325e71a3bf6b4b106429a389
https://biblio.ugent.be/publication/8040756/file/8040857
https://biblio.ugent.be/publication/8040756/file/8040857
Autor:
Koopman, Werner JH, Beyrath, Julien, Fung, Cheuk‐Wing, Koene, Saskia, Rodenburg, Richard J, Willems, Peter HGM, Smeitink, Jan AM
Publikováno v:
EMBO Molecular Medicine; Apr2016, Vol. 8 Issue 4, p311-327, 17p
Autor:
Sieprath, Tom, Corne, Tobias DJ, Nooteboom, Marco, Grootaert, Charlotte, Rajkovic, Andreja, Buysschaert, Benjamin, Robijns, Joke, Broers, Jos LV, Ramaekers, Frans CS, Koopman, Werner JH, Willems, Peter HGM, De Vos, Winnok H
Publikováno v:
Nucleus (1949-1034); 2015, Vol. 6 Issue 3, p236-246, 11p
Publikováno v:
EMBO Journal; 1/9/2013, Vol. 32 Issue 1, p9-29, 21p, 4 Diagrams, 1 Chart, 1 Graph
Autor:
Schöckel L; BPH, GDD, Global Therapeutic Research Group Oncology II, Bayer Pharma AG, Müllerstraße 178, 13353 Berlin, Germany., Glasauer A; BPH, GDD, Global Therapeutic Research Group Oncology II, Bayer Pharma AG, Müllerstraße 178, 13353 Berlin, Germany., Basit F; Department of Biochemistry, Radboud Institute for Molecular Life Science (RIMLS), Radboud University Medical Centre (RUMC), Nijmegen, The Netherlands., Bitschar K; BPH, GDD, Global Therapeutic Research Group Oncology II, Bayer Pharma AG, Müllerstraße 178, 13353 Berlin, Germany., Truong H; Department of Biochemistry, Radboud Institute for Molecular Life Science (RIMLS), Radboud University Medical Centre (RUMC), Nijmegen, The Netherlands., Erdmann G; BPH, GDD, Global Therapeutic Research Group Oncology II, Bayer Pharma AG, Müllerstraße 178, 13353 Berlin, Germany., Algire C; BPH, GDD, Global Therapeutic Research Group Oncology II, Bayer Pharma AG, Müllerstraße 178, 13353 Berlin, Germany., Hägebarth A; BPH, GDD, Global Therapeutic Research Group Oncology II, Bayer Pharma AG, Müllerstraße 178, 13353 Berlin, Germany., Willems PH; Department of Biochemistry, Radboud Institute for Molecular Life Science (RIMLS), Radboud University Medical Centre (RUMC), Nijmegen, The Netherlands., Kopitz C; BPH, GDD, Global Therapeutic Research Group Oncology II, Bayer Pharma AG, Müllerstraße 178, 13353 Berlin, Germany., Koopman WJ; Department of Biochemistry, Radboud Institute for Molecular Life Science (RIMLS), Radboud University Medical Centre (RUMC), Nijmegen, The Netherlands., Héroult M; Bayer AG Innovation Strategy, Kaiser Wilhelm Allee 1, 51368 Leverkusen, Germany.
Publikováno v:
Cancer & metabolism [Cancer Metab] 2015 Oct 20; Vol. 3, pp. 11. Date of Electronic Publication: 2015 Oct 20 (Print Publication: 2015).